Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies.

Kalwak K, Mielcarek M, Patrick K, Styczynski J, Bader P, Corbacioglu S, Burkhardt B, Sykora KW, Drabko K, Gozdzik J, Fagioli F, Greil J, Gruhn B, Beier R, Locatelli F, Müller I, Schlegel PG, Sedlacek P, Stachel KD, Hemmelmann C, Möller AK, Baumgart J, Vora A.

Bone Marrow Transplant. 2020 Mar 20. doi: 10.1038/s41409-020-0869-6. [Epub ahead of print]

PMID:
32203268
2.

First-line treatment failure in childhood acute lymphoblastic leukemia: The polish pediatric leukemia and lymphoma study group experience.

Zawitkowska J, Lejman M, Drabko K, Zaucha-Prażmo A, Płonowski M, Bulsa J, Romiszewski M, Mizia-Malarz A, Kołtan A, Derwich K, Karolczyk G, Ociepa T, Ćwiklińska M, Trelińska J, Owoc-Lempach J, Niedźwiecki M, Kiermasz A, Kowalczyk J.

Medicine (Baltimore). 2020 Feb;99(7):e19241. doi: 10.1097/MD.0000000000019241.

3.

Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis.

Capo V, Penna S, Merelli I, Barcella M, Scala S, Basso-Ricci L, Draghici E, Palagano E, Zonari E, Desantis G, Uva P, Cusano R, Sergi Sergi L, Crisafulli L, Moshous D, Stepensky P, Drabko K, Kaya Z, Unal E, Gezdirici A, Menna G, Serafini M, Aiuti A, Locatelli SL, Carlo-Stella C, Schulz AS, Ficara F, Sobacchi C, Gentner B, Villa A.

Haematologica. 2020 Jan 16. pii: haematol.2019.238261. doi: 10.3324/haematol.2019.238261. [Epub ahead of print]

4.

Impact of early chimerism status on clinical outcome in children with acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.

Lejman M, Zaucha-Prażmo A, Zawitkowska J, Mroczkowska A, Grabowski D, Kowalczyk JR, Drabko K.

BMC Cancer. 2019 Nov 26;19(1):1141. doi: 10.1186/s12885-019-6360-3.

5.

Influence of Mixed Chimerism on Outcome in Children With Anaemia After Haematopoietic Stem Cell Transplantation.

Lejman M, Zawitkowska J, Zaucha-Prażmo A, Cienkusz M, Mroczkowska A, Kowalczyk J, Drabko K.

In Vivo. 2019 Nov-Dec;33(6):2051-2057. doi: 10.21873/invivo.11703.

6.

Severe drug-induced hypertriglyceridemia treated with plasmapheresis in children with acute lymphoblastic leukemia.

Zawitkowska J, Lejman M, Zaucha-Prażmo A, Sekuła N, Greczkowska-Chmiel T, Drabko K.

Transfus Apher Sci. 2019 Oct;58(5):634-637. doi: 10.1016/j.transci.2019.08.025. Epub 2019 Sep 5.

PMID:
31515171
7.

Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial.

Kowalczyk JR, Zawitkowska J, Lejman M, Drabko K, Samardakiewicz M, Matysiak M, Romiszewski M, Balwierz W, Ćwiklińska M, Kazanowska B, Owoc-Lempach J, Wachowiak J, Derwich K, Adamkiewicz-Drożyńska E, Niedźwiecki M, Trelińska J, Młynarski W, Wysocki M, Kołtan A, Szczepański T, Krawczuk-Rybak M, Kitszel A, Wieczorek M, Urasiński T, Ociepa T, Sobol-Milejska G, Mizia-Malarz A, Karolczyk G, Stary J.

Am J Hematol. 2019 Nov;94(11):E307-E310. doi: 10.1002/ajh.25619. Epub 2019 Aug 30. No abstract available.

8.

Salivary and serum concentrations of selected pro- and antiinflammatory cytokines in relation to oral lesions among children undergoing maintenance therapy of acute lymphoblastic leukemia.

Krzaczek PM, Mitura-Lesiuk M, Zawitkowska J, Petkowicz B, Wilczyńska B, Drabko K.

Contemp Oncol (Pozn). 2019;23(2):81-86. doi: 10.5114/wo.2019.85878. Epub 2019 Jun 13.

9.

Grade 3 and 4 Toxicity Profiles During Therapy of Childhood Acute Lymphoblastic Leukemia.

Zawitkowska J, Lejman M, Zaucha-Prażmo A, Drabko K, Płonowski M, Bulsa J, Romiszewski M, Mizia-Malarz A, Kołtan A, Derwich K, Karolczyk G, Ociepa T, Ćwiklińska M, Trelińska J, Owoc-Lempach J, Niedźwiecki M, Kiermasz A, Kowalczyk J.

In Vivo. 2019 Jul-Aug;33(4):1333-1339. doi: 10.21873/invivo.11608.

10.

Risk Factors for Transplant Outcomes in Children and Adolescents with Non-Malignant Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation.

Zaucha-Prażmo A, Sadurska E, Pieczonka A, Goździk J, Dębski R, Drabko K, Zawitkowska J, Lejman M, Wachowiak J, Styczyński J, Kowalczyk JR.

Ann Transplant. 2019 Jun 25;24:374-382. doi: 10.12659/AOT.915330.

11.

Infectious profile in children with ALL during chemotherapy: A report of study group for infections.

Zawitkowska J, Drabko K, Szmydki-Baran A, Zaucha-Prażmo A, Lejman M, Czyżewski K, Zalas-Więcek P, Gryniewicz-Kwiatkowska O, Czajńska-Deptuła A, Kulicka E, Semczuk K, Hutnik Ł, Chełmecka-Wiktorczyk L, Klepacka J, Frączkiewicz J, Salamonowicz M, Tomaszewska R, Zając-Spychała O, Irga-Jaworska N, Bień E, Płonowski M, Bartnik M, Ociepa T, Pierlejewski F, Woszczyk M, Gamrot-Pyka Z, Małas Z, Urbanek-Dądela A, Stolpa W, Musiał J, Styczyński J.

J Infect Chemother. 2019 Oct;25(10):774-779. doi: 10.1016/j.jiac.2019.04.005. Epub 2019 May 14.

PMID:
31101529
12.

Predicting Ewing Sarcoma Treatment Outcome Using Infrared Spectroscopy and Machine Learning.

Chaber R, Arthur CJ, Łach K, Raciborska A, Michalak E, Bilska K, Drabko K, Depciuch J, Kaznowska E, Cebulski J.

Molecules. 2019 Mar 19;24(6). pii: E1075. doi: 10.3390/molecules24061075.

13.

Prediction of Ewing Sarcoma treatment outcome using attenuated tissue reflection FTIR tissue spectroscopy.

Chaber R, Łach K, Arthur CJ, Raciborska A, Michalak E, Ciebiera K, Bilska K, Drabko K, Cebulski J.

Sci Rep. 2018 Aug 17;8(1):12299. doi: 10.1038/s41598-018-29795-8.

14.

Clinical characteristics and analysis of treatment result in children with Ph-positive acute lymphoblastic leukaemia in Poland between 2005 and 2017.

Zawitkowska J, Lejman M, Zaucha-Prażmo A, Drabko K, Płonowski M, Bulsa J, Romiszewski M, Mizia-Malarz A, Kołtan A, Derwich K, Karolczyk G, Ociepa T, Ćwiklińska M, Trelińska J, Owoc-Lempach J, Niedźwiecki M, Kiermasz A, Kowalczyk J.

Eur J Haematol. 2018 Oct;101(4):542-548. doi: 10.1111/ejh.13142. Epub 2018 Aug 31.

PMID:
30007093
15.

Development and current use of in hematopoietic stem cell transplantation in children and adolescents in Poland: Report of the Polish pediatric study group for hematopoietic stem cell transplantation of the Polish society for pediatric oncology and hematology.

Wachowiak J, Chybicka A, Kowalczyk JR, Wysocki M, Goździk J, Gorczyńska E, Kałwak K, Styczyński J, Drabko K, Pieczonka A.

Transfus Apher Sci. 2018 Jun;57(3):316-322. doi: 10.1016/j.transci.2018.05.012. Epub 2018 May 16. Review.

PMID:
29880247
16.

HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor.

Nowak J, Nestorowicz K, Graczyk-Pol E, Mika-Witkowska R, Rogatko-Koros M, Jaskula E, Koscinska K, Madej S, Tomaszewska A, Nasilowska-Adamska B, Szczepinski A, Halaburda K, Dybko J, Kuliczkowski K, Czerw T, Giebel S, Holowiecki J, Baranska M, Pieczonka A, Wachowiak J, Czyz A, Gil L, Lojko-Dankowska A, Komarnicki M, Bieniaszewska M, Kucharska A, Hellmann A, Gronkowska A, Jedrzejczak WW, Markiewicz M, Koclega A, Kyrcz-Krzemien S, Mielcarek M, Kalwak K, Styczynski J, Wysocki M, Drabko K, Wojcik B, Kowalczyk J, Gozdzik J, Pawliczak D, Gwozdowicz S, Dziopa J, Szlendak U, Witkowska A, Zubala M, Gawron A, Warzocha K, Lange A.

Hum Immunol. 2018 Jun;79(6):403-412. doi: 10.1016/j.humimm.2018.03.011. Epub 2018 Mar 29.

PMID:
29605688
17.

Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas.

Janeczko-Czarnecka M, Krawczuk-Rybak M, Karpińska-Derda I, Niedźwiecki M, Musioł K, Ćwiklińska M, Drabko K, Mycko K, Ociepa T, Pawelec K, Januszkiewicz-Lewandowska D, Ussowicz M, Rybka B, Ryczan-Krawczyk R, Kołtan A, Karolczyk G, Zaucha-Prażmo A, Badowska W, Kałwak K.

Adv Clin Exp Med. 2018 Jan;27(1):91-98. doi: 10.17219/acem/66462.

18.

Transplant-related mortality and survival in children with malignancies treated with allogeneic hematopoietic stem cell transplantation. A multicenter analysis.

Zaucha-Prazmo A, Gozdzik J, Debski R, Drabko K, Sadurska E, Kowalczyk JR.

Pediatr Transplant. 2018 May;22(3):e13158. doi: 10.1111/petr.13158. Epub 2018 Feb 3.

PMID:
29396905
19.

Incidence of Infectious Complications in Children With Acute Lymphoblastic Leukemia Treated With Hematopoietic Stem Cell Transplantation.

Zaucha-Prażmo A, Kowalczyk JR, Drabko K, Czyżewski K, Goździk J, Zając-Spychała O, Wachowiak J, Frączkiewicz J, Gorczyńska E, Kałwak K, Styczyński J.

Transplant Proc. 2017 Nov;49(9):2183-2187. doi: 10.1016/j.transproceed.2017.09.027.

PMID:
29149980
20.

Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.

Zawitkowska J, Odój T, Drabko K, Zaucha-Prażmo A, Rudnicka J, Romiszewski M, Matysiak M, Kwiecińska K, Ćwiklińska M, Balwierz W, Owoc-Lempach J, Derwich K, Wachowiak J, Niedźwiecki M, Adamkiewicz-Drożyńska E, Trelińska J, Młynarski W, Kołtan A, Wysocki M, Tomaszewska R, Szczepański T, Płonowski M, Krawczuk-Rybak M, Ociepa T, Urasiński T, Mizia-Malarz A, Sobol-Milejska G, Karolczyk G, Kowalczyk J.

Pediatr Hematol Oncol. 2017 May;34(4):199-205. doi: 10.1080/08880018.2017.1363837. Epub 2017 Oct 17.

PMID:
29040012
21.

Usefulness of Post-Transplant Hematopoietic Chimera Monitoring by Use of the Quantitative Fluorescence Polymerase Chain Reaction Method.

Lejman M, Drabko K, Styka B, Winnicka D, Babicz M, Jaszczuk I, Kowalczyk JR.

Transplant Proc. 2017 Oct;49(8):1903-1910. doi: 10.1016/j.transproceed.2017.04.013.

PMID:
28923646
22.

Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.

Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K, Kalwak K, Kanazawa N, Karasu G, Kucuk ZY, Laberko A, Lange A, Mahlaoui N, Meisel R, Moshous D, Muramatsu H, Parikh S, Pasic S, Schmid I, Schuetz C, Schulz A, Schultz KR, Shaw PJ, Slatter MA, Sykora KW, Tamura S, Taskinen M, Wawer A, Wolska-Kuśnierz B, Cowan MJ, Fischer A, Gennery AR; Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiencies; Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE); Center for International Blood and Marrow Transplant Research; Primary Immunodeficiency Treatment Consortium.

J Allergy Clin Immunol. 2018 Jan;141(1):322-328.e10. doi: 10.1016/j.jaci.2017.02.036. Epub 2017 Apr 7.

23.

Can we find a good biochemical marker of early cardiotoxicity in children treated with haematopoietic stem cell transplantation?

Zaucha-Prażmo A, Sadurska E, Drabko K, Kowalczyk JR.

Contemp Oncol (Pozn). 2016;20(3):220-4. doi: 10.5114/wo.2016.61563. Epub 2016 Aug 4.

24.

Impairment of Immune Function in Children with Familial Hemophagocytic Lymphohistiocytosis.

Popko K, Jasińska J, Górska E, Demkow U, Balwierz W, Maciejka-Kembłowska L, Badowska W, Wachowiak J, Drabko K, Malinowska I.

Adv Exp Med Biol. 2016;912:21-31. doi: 10.1007/5584_2016_210.

PMID:
26987330
25.

Management and follow-up of Ewing sarcoma patients with isolated lung metastases.

Raciborska A, Bilska K, Rychłowska-Pruszyńska M, Duczkowski M, Duczkowska A, Drabko K, Chaber R, Sobol G, Wyrobek E, Michalak E, Rodriguez-Galindo C, Wożniak W.

J Pediatr Surg. 2016 Jul;51(7):1067-71. doi: 10.1016/j.jpedsurg.2015.11.012. Epub 2015 Nov 24.

PMID:
26707423
26.

Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.

Wolska-Kuśnierz B, Gregorek H, Chrzanowska K, Piątosa B, Pietrucha B, Heropolitańska-Pliszka E, Pac M, Klaudel-Dreszler M, Kostyuchenko L, Pasic S, Marodi L, Belohradsky BH, Čižnár P, Shcherbina A, Kilic SS, Baumann U, Seidel MG, Gennery AR, Syczewska M, Mikołuć B, Kałwak K, Styczyński J, Pieczonka A, Drabko K, Wakulińska A, Gathmann B, Albert MH, Skarżyńska U, Bernatowska E; Inborn Errors Working Party of the Society for European Blood and Marrow Transplantation and the European Society for Immune Deficiencies.

J Clin Immunol. 2015 Aug;35(6):538-49. doi: 10.1007/s10875-015-0186-9. Epub 2015 Aug 14.

PMID:
26271390
27.

Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.

Raciborska A, Bilska K, Drabko K, Michalak E, Chaber R, Pogorzała M, Połczyńska K, Sobol G, Wieczorek M, Muszyńska-Rosłan K, Rychlowska-Pruszyńska M, Rodriguez-Galindo C, Dziuk M.

Clin Transl Oncol. 2016 Feb;18(2):189-95. doi: 10.1007/s12094-015-1351-6. Epub 2015 Aug 7.

PMID:
26250765
28.

Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.

Bogunia-Kubik K, Mizia S, Polak M, Gronkowska A, Nowak J, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Koclęga A, Sędzimirska M, Suchnicki K, Duda D, Lange J, Mordak-Domagała M, Kościńska K, Jędrzejczak WW, Kaczmarek B, Hellmann A, Kucharska A, Kowalczyk J, Drabko K, Warzocha K, Hałaburda K, Tomaszewska A, Mika-Witkowska R, Witkowska A, Goździk J, Mordel A, Wysoczańska B, Jaskula E, Lange A; POLISH DONOR–RECIPIENT STUDY GROUP.

Cytokine. 2015 Dec;76(2):182-186. doi: 10.1016/j.cyto.2015.05.001. Epub 2015 May 14.

PMID:
25982843
29.

CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor.

Bogunia-Kubik K, Mizia S, Gronkowska A, Nowak J, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Koclęga A, Sędzimirska M, Suchnicki K, Duda D, Lange J, Mordak-Domagała M, Kościńska K, Węzik S, Jędrzejczak WW, Kaczmarek B, Hellmann A, Kucharska A, Kowalczyk J, Drabko K, Warzocha K, Mika-Witkowska R, Goździk J, Lange A.

Br J Haematol. 2015 Oct;171(2):285-288. doi: 10.1111/bjh.13387. Epub 2015 Mar 30. No abstract available.

PMID:
25823722
30.
31.

Ovarian function in female survivors after multimodal Ewing sarcoma therapy.

Raciborska A, Bilska K, Filipp E, Drabko K, Rogowska E, Chaber R, Pogorzała M, Połczyńska K, Adrianowska N, Rodriguez-Galindo C, Maciejewski T.

Pediatr Blood Cancer. 2015 Feb;62(2):341-345. doi: 10.1002/pbc.25304. Epub 2014 Nov 15.

PMID:
25399867
32.

Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.

Nowak J, Kościńska K, Mika-Witkowska R, Rogatko-Koroś M, Mizia S, Jaskuła E, Polak M, Mordak-Domagała M, Lange J, Gronkowska A, Jędrzejczak WW, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Tomaszewska A, Nasiłowska-Adamska B, Szczepiński A, Hałaburda K, Hellmann A, Czyż A, Gil L, Komarnicki M, Wachowiak J, Barańska M, Kowalczyk J, Drabko K, Goździk J, Wysoczańska B, Bogunia-Kubik K, Graczyk-Pol E, Witkowska A, Marosz-Rudnicka A, Nestorowicz K, Dziopa J, Szlendak U, Warzocha K, Lange A; Polish Donor-Recipient Matching Study Group.

Biol Blood Marrow Transplant. 2015 May;21(5):829-39. doi: 10.1016/j.bbmt.2015.01.018. Epub 2015 Jan 21.

33.

Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients.

Gozdzik J, Rewucka K, Krasowska-Kwiecien A, Pieczonka A, Debski R, Zaucha-Prazmo A, Drabko K, Krukowska-Jaros J, Wozniak M, Kowalczyk J, Wysocki M, Gorczynska E, Kalwak K, Chybicka A, Wachowiak J.

Bone Marrow Transplant. 2015 Jan;50(1):51-5. doi: 10.1038/bmt.2014.200. Epub 2014 Oct 13.

PMID:
25310307
34.

Internal hemipelvectomy in the management of pelvic Ewing sarcoma - are outcomes better than with radiation therapy?

Raciborska A, Bilska K, Rychlowska-Pruszynska M, Drabko K, Chaber R, Pogorzała M, Połczyńska K, Godziński J, Rodriguez-Galindo C, Wożniak W.

J Pediatr Surg. 2014 Oct;49(10):1500-4. doi: 10.1016/j.jpedsurg.2014.04.013. Epub 2014 Jul 4.

PMID:
25280655
35.

Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.

Raciborska A, Bilska K, Drabko K, Chaber R, Sobol G, Pogorzała M, Wyrobek E, Połczyńska K, Rogowska E, Rodriguez-Galindo C, Wożniak W.

Pediatr Blood Cancer. 2014 Dec;61(12):2170-4. doi: 10.1002/pbc.25167. Epub 2014 Aug 27.

PMID:
25163763
36.
37.

Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.

Nowak J, Kościńska K, Mika-Witkowska R, Rogatko-Koroś M, Mizia S, Jaskuła E, Polak M, Mordak-Domagała M, Lange J, Gronkowska A, Jędrzejczak WW, Kyrcz-Krzemień S, Markiewicz M, Dzierżak-Mietła M, Tomaszewska A, Nasiłowska-Adamska B, Szczepiński A, Hałaburda K, Hellmann A, Komarnicki M, Gil L, Czyż A, Wachowiak J, Barańska M, Kowalczyk J, Drabko K, Goździk J, Wysoczańska B, Bogunia-Kubik K, Graczyk-Pol E, Witkowska A, Marosz-Rudnicka A, Nestorowicz K, Dziopa J, Szlendak U, Warzocha K, Lange AA; Polish Donor-Recipient Matching Study Group.

Am J Hematol. 2014 Oct;89(10):E176-83. doi: 10.1002/ajh.23802. Epub 2014 Aug 27.

38.

IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation.

Jaskula E, Lange A, Dlubek D, Kyrcz-Krzemień S, Markiewicz M, Dzierzak-Mietla M, Jedrzejczak WW, Gronkowska A, Nowak J, Warzocha K, Hellmann A, Kowalczyk J, Drabko K, Goździk J, Mizia S; Polish Donor‐Recipient Matching Group.

Tissue Antigens. 2013 Dec;82(6):387-96. doi: 10.1111/tan.12255.

PMID:
24498995
39.

NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.

Jaskula E, Lange A, Kyrcz-Krzemien S, Markiewicz M, Dzierzak-Mietla M, Jedrzejczak WW, Czajka P, Mordak-Domagala M, Lange J, Gronkowska A, Nowak J, Warzocha K, Hellmann A, Kowalczyk J, Drabko K, Gozdzik J, Mizia S; Polish Donor-Recipient Matching Group.

Biol Blood Marrow Transplant. 2014 Mar;20(3):409-14. doi: 10.1016/j.bbmt.2013.12.558. Epub 2013 Dec 15.

40.

[Chemotherapy in patients with refractory Ewing sarcoma].

Raciborska A, Bilska K, Drabko K, Rogowska E, Chaber R, Pogorzała M, Wyrobek E, Połczyńska K, Rodriguez-Galindo C, Woźniak W.

Med Wieku Rozwoj. 2013 Apr-Jun;17(2):117-25. Polish.

PMID:
23988368
41.

Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma.

Raciborska A, Bilska K, Drabko K, Chaber R, Pogorzala M, Wyrobek E, Polczyńska K, Rogowska E, Rodriguez-Galindo C, Wozniak W.

Pediatr Blood Cancer. 2013 Oct;60(10):1621-5. doi: 10.1002/pbc.24621. Epub 2013 Jun 15.

PMID:
23776128
42.

Significant changes in the composition of the precursor B-cell compartment in children less than 2 years old.

Piątosa B, Birbach M, Siewiera K, Ussowicz M, Kałwak K, Drabko K, Rękawek A, Tkaczyk K, Kurowski PN.

Cytometry B Clin Cytom. 2013 May;84(3):179-86. doi: 10.1002/cyto.b.21085. Epub 2013 Mar 8.

43.

Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma.

Drabko K, Raciborska A, Bilska K, Styczynski J, Ussowicz M, Choma M, Wojcik B, Zaucha-Prazmo A, Gorczynska E, Skoczen S, Wozniak W, Chybicka A, Wysocki M, Gozdzik J, Kowalczyk J.

Bone Marrow Transplant. 2012 Dec;47(12):1530-4. doi: 10.1038/bmt.2012.78. Epub 2012 May 21.

PMID:
22609883
44.

[Megachemotherapy and autologous stem cell transplantation in children with Ewing sarcoma - Polish experience].

Drabko K, Zaucha-Prazmo A, Choma M, Wójcik B, Dyla A, Paździor D, Kałwak K, Chybicka A, Skoczeń S, Goździk J, Styczyński J, Wysocki M, Kowalczyk J.

Med Wieku Rozwoj. 2008 Oct-Dec;12(4 Pt 2):1069-73. Polish.

PMID:
19531828
45.

Neurologic complications in children after hemaopoietic stem cell transplantation: a single-center experience.

Zaucha-Prazmo A, Jasiński M, Drabko K, Choma M, Wójcik B, Kowalczyk JR.

Transplant Proc. 2007 Nov;39(9):2905-7.

PMID:
18022013
47.

[Megachemotherapy and autologous hematopoietic stem cell transplantation in children with solid tumours excluding neuroblastoma--experience of Polish paediatric centres].

Drabko K, Choma M, Zaucha-Prazmo A, Wójcik B, Gorczyńska E, Kałwak K, Turkiewicz D, Słociak M, Ussowicz M, Dyla A, Chybicka A, Styczyński J, Debski R, Wysocki M, Goździk J, Ratajczak M, Kowalczyk JR.

Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Pt 1):785-92. Polish.

PMID:
17317909
48.

[High-dose therapy followed by auto HSCT in children--with advanced neuroblastoma in four transplant centres in Poland].

Zaucha-Prazmo A, Drabko K, Wójcik B, Choma M, Kałwak K, Gorczyńska E, Turkiewicz D, Słociak M, Ussowicz M, Dyla A, Chybicka A, Goździk J, Ratajczak M, Styczyński J, Debski R, Wysocki M, Kowalczyk J.

Med Wieku Rozwoj. 2006 Jul-Sep;10(3 Pt 1):775-84. Polish.

PMID:
17317908
49.

[Megachemotherapy followed by autologous haematopoietic stem cell rescue in children with high risk CNS tumours].

Drabko K, Wiśniewska-Slusarz H, Wójcik B, Choma M, Zaucha-Prazmo A, Kowalczyk JR.

Med Wieku Rozwoj. 2005 Jul-Sep;9(3 Pt 2):439-47. Polish.

PMID:
16719156
50.

Donor origin of Graves disease in a BMT recipient: evidence from FISH studies of thyroid tissue.

Drabko K, Winnicka D, Gaworczyk A, Beń-Skowronek I, Skomra D, Kowalczyk JR.

Bone Marrow Transplant. 2006 Apr;37(8):789-91. No abstract available.

PMID:
16518432

Supplemental Content

Loading ...
Support Center